Case studies

MAP’s vision to accelerate patient access to medicines, devices and diagnostics is at the heart of everything we do.

Case studies

To showcase our unique and highly effective ‘blended’ methodology to Market Access Consultancy assignments, we have created the following real world examples.

Each case study details the particular client focussed Market Access challenge, our approach plus the results achieved.  

  •  Supporting our client with a successful submission to NICE’s Highly Specialised Technology (HST) programme

  •  Helping a growing US biopharma company navigate product reimbursement across Europe

  •  Supporting our client through the UK Promising Innovative Medicine (PIM) designation as part of the Early Access to Medicines Scheme (EAMS)

  •  Securing a price rise for an existing medicine

  •  Removing our client’s high-cost medicine from the NHS tariff

  •  Improving access to orphan medicines and helping to strengthen the case for change

  •  Securing a change in a proposed NHS England prescribing restriction for acute pain medication in primary care

  •  Putting our global client and their key issue on the UK map

    If your organisation is experiencing any of the same scenarios and would like some support, please book a free scoping call with one of our Market Access experts

CareersTerms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

 +44 (0) 1480 832360

MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281

VAT Group Registration Number:
GB 292 8576 52